On June 29, join our annual Healthcare Forum
Although still a small market ($1.8B in 2021), health-focused VR has shown potential in treating a range of conditions, from phobias to chronic pain. The market is projected to reach $9.5B by 2028 (Washington Post).
Already, VR is helping treat patients. One of the most successful areas has been post-traumatic stress disorder (the Veterans Health Administration was an early adopter) and has also been used to reduce pain and anxiety without medication. VR has become an important educational tool, allowing students to practice procedures and prepare for high-risk scenarios (surgeons trained with VR have shown significantly fewer errors than traditional training methods.) And, fyi, VRARA Member UCF, has implemented VR/AR for nurses over the past year. And, Arizona State replaces all intro biology labs with VR labs.
On June 29, our annual Healthcare Forum will have 40+ speakers, 800+ attendees from Microsoft, Bloomberg, Magic Leap, Tel Aviv Medical Center, Merck, Thermo Fisher, Harvard, Compal, Edwards, Pacific Neurocenter, Canon, MIT, NYU, CAE, Sony, Intel, TAMP (with doctors from US, Europe, Brazil, Nigeria, India), and many others.
